Buntanetap for Parkinson's disease study
Part of Brain & nervous system clinical trials.
This trial tests an investigational drug called buntanetap in people with Parkinson's disease. It aims to see if the drug can improve symptoms. There are two groups: those who've taken buntanetap before (Cohort 1) and those with a deep brain stimulator (DBS) implant for at least a year (Cohort 2).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of Parkinson's disease and are between 40 and 85 years old.
- If you have never taken buntanetap before, you must have a deep brain stimulator (DBS) that has been working well for at least 12 months.
- You can walk and move (Hoehn and Yahr stage 1-3) when your medication is working (ON state).
- You have a thinking test score (MMSE) between 21 and 30.
- You have a support person who can come with you to study visits.
- You agree to use effective birth control if needed, and are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to program deep brain stimulation (DBS) using brain signals, which may improve symptom control. It is for people with Parkinson's who have a Medtronic Percept DBS device and are ready for their first programming session.
This study looks at how your own ratings of your Parkinson's symptoms can help fine-tune your deep brain stimulation (DBS) settings. It is for people with Parkinson's who already have a DBS device that can record brain activity.
This trial tests a new type of deep brain stimulation that adapts to your movements to improve walking, balance, and tremors. It is for people with Parkinson's disease who have had symptoms for at least 3 years, are 21 to 75 years old, and already have a special study brain-stimulation device implanted.
This study looks at how the brain “filters” sensory information in people with advanced Parkinson’s disease, using brain imaging and deep brain stimulation (DBS) that you may already be getting as routine care. The goal is to better understand what drives Parkinson’s symptoms and how DBS might affect the brain.
This study tests an approach to improving Parkinson’s symptoms in people who already have deep brain stimulation (DBS) devices. It focuses on patients who are able to do walking tests safely and confirm they can understand and consent.
This trial studies how deep brain stimulation (DBS) works and can help control Parkinson's symptoms. It uses a special DBS device that is safe for MRI scans.
Hear when a new Deep Brain Stimulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.